Article
Reduction of the Neointimal hyperplasia and calcification in arterialised fistula veins – the effect of vitamin K2 in a CKD/uraemia Rat model
Search Medline for
Authors
Published: | May 20, 2011 |
---|
Outline
Text
Introduction: Neointimal hyperplasia is the main cause of arteriovenous fistula (AVF) failure in chronic kidney disease (CKD) patients while access calcification predicts mortality. Low vitamin K2 intake has been associated with a higher incidence of calcification in the cardiovascular system, through disturbed carboxylation equilibrium of vitamin K-dependent proteins.
Materials and methods: To determine the influence of vitamin K2 we used a rat model that that depicts the influence of CKD in the function of an AVF. The induction of CKD followed an adenine rich diet and the AVFs were micro surgically made in the femoral vessels of the right groin of the rats. The animals were divided in groups fed with normal and adenine rich diet, while two subgroups of the adenine fed animals were either pre fed with food supplemented with vitamin K2 (preventive group), or fed after operation with vitamin K2 (therapeutic group). The animals were sacrificed in days 21, 42 and 63.
Results: There was a significant increase of the neointimal hyperplasia at all time points between the healthy and the CKD animals (p<0.0001) along with a significant shrinking of the media (p<0.0001) and a significant calcification of the venous wall (p<0.0001). The CDK animals that were fed with vitamin K2 presented a significantly lesser neointimal hyperplasia (p<0.0002 for both therapeutic and preventive groups), less shrinking of the media (p<0.0001) compared to the CKD animals without K2 supplement. Significant was the calcification reduction for both therapeutic and preventive groups compared to the non K2 treated CKD animals (p<0.0001).
Conclusion: Vitamin K2 in either a preventive or a therapeutic intake protocol is involved not only in the calcification pathology but also in the neointimal hyperplasia formation making it an even more important therapeutic candidate for dialysis patients.